Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis

Transplantation

Volumn 78, Issue 8, 2004, Pages 1225-1228

  Morioka, Daisuke ^a,b   Sekido, Hitoshi ^a   Kubota, Kaori ^a   Sugita, Mitsutaka ^a   Tanaka, Kuniya ^a   Togo, Shinji ^a   Yamanaka, Shoji ^a   Sasaki, Takeshi ^a   Inayama, Yoshiaki ^a   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

ABO incompatible liver transplantation; Antibody mediated rejection; Gamma globulin bolus infusion

Indexed keywords

CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; GABEXATE MESILATE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN E1; RITUXIMAB; TACROLIMUS;

ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BOLUS INJECTION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; PLASMAPHERESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SPLENECTOMY;

ABO BLOOD-GROUP SYSTEM; BIOPSY; BLOOD GROUP INCOMPATIBILITY; FEMALE; GAMMA-GLOBULINS; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFUSIONS, INTRAVENOUS; ISOANTIBODIES; LIVER; LIVER TRANSPLANTATION; MIDDLE AGED; PLASMAPHERESIS; RECOVERY OF FUNCTION;

EID: 7044239098     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000137264.99113.2B     Document Type: Article

References (19)

1. Demetris AJ, Jaffe R, Tzakis A, et al. Antibody-mediated rejection of human orthotopic liver allograft. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988; 132: 489.
2. Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet 1990; 336: 519.
3. Lo CM, Shaked A, Busuttil RW. Risk factors for liver transplantation across the ABO barrier. Transplantation 1994; 58: 543.
4. Wu A, Buhler LH, Cooper DK. ABO-incompatible organ and bone marrow transplantation: current status. Transpl Int 2003; 16: 291.
5. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004; 77: 403.
6. Farges O, Kalil AN, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995; 59: 1124.
7. Bjoro K, Ericzon BG, Kirkegaard P, et al. Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 2003; 75: 347.
8. Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2003; 73: 1959.
9. Hanto DW, Fecteau AH, Alonso MH, et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transplant 2003; 9: 22.
10. Oike F, Kamei H, Tanaka K. Novel approaches for ABO blood-type incompatible liver transplantation from living donor: intraportal infusion therapy and hepatic arterial infusion therapy. Konnichi No Ishoku 2003; 16: 479.
11. Sekido H, Matsuo K, Takeda K, et al. Successful adult ABO-incompatible liver transplantation: therapeutic strategy for thrombotic microangiopathy is the key to success. Transplantation 2003; 75: 1605.
12. Sawada T, Fuchinoue S, Teraoka S. Successful Al-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 2002; 74: 1207.
13. Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887.
14. Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 1998; 65: 224.
15. Sinmmura H, Tanabe K, Ishikawa N, et al. Roll of anti-A/B antibody in results of ABO-incompatible kidney transplantation. Transplantation 2000; 70: 1331.
16. Toma H, Tanabe K, Tokumoto T. Long-term outcome of ABO-incompatible renal transplantation. Urol Clin North Am 2001; 28: 769.
17. Gloor JM, Lager DJ, Moore B, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971.
18. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730.
19. Haga H, Egawa H, Shirase T, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transplant 2004; 10: 16.